QIAGEN, Bode Technology Enter Multi-year Agreement For GEDmatch PRO Genealogy Database
Portfolio Pulse from Benzinga Newsdesk
QIAGEN's subsidiary Verogen and Bode Technology have entered a multi-year agreement to enhance the GEDmatch PRO genealogy database for forensic use. Bode will handle global commercial transactions, while QIAGEN focuses on feature development.
September 23, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
QIAGEN's subsidiary Verogen has entered a multi-year agreement with Bode Technology to enhance the GEDmatch PRO database, focusing on forensic genealogy. This partnership may boost QIAGEN's market position in forensic solutions.
The partnership with Bode Technology to enhance GEDmatch PRO positions QIAGEN as a leader in forensic genealogy, potentially increasing demand for its solutions. This could positively impact QIAGEN's stock in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80